Structural Heart Occluders/Closure Devices

AGA Amplatzer ASD closure

The U.S. Food and Drug Administration (FDA) issued a warning this week about safety issues encountered with the St. Jude Amplatzer Atrial Septal Occluder (ASO), a transcatheter device used to seal congenital holes in the atrial septum. The FDA rep...

August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit-Occlud Patent Ductus Arteriosus (PDA) device, a permanently implanted prosthesis indicated for percutaneous, transcatheter closure...

Transcatheter structural heart repair devices deployed in the cath lab have largely replaced open-heart surgery as the therapy of choice. Percutaneously deployed septal occluders make it possible to repair atrial septal defects with better outcome...

Boston Scientific, Watchman LAA device, FDA approval
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman...
October 13, 2014 — After reviewing updated data and analysis for the Boston Scientific Watchman left atrial appendage (LAA) closure device, the U.S. Food and...
Occlutech announced that it has successfully obtained a ruling by the U.K. Patents Court in the High Court of Justice in London that invalidates AGA/St Jude's...
ACC, iPad cardiology apps
DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.
Boston Scientific, Watchman LAA device, FDA approval
The Watchman left atrial appendage closure device from Boston Scientific Corp. is a catheter-delivered heart implant designed to close the
PFM Medical's Nit-Occlud Patent Ductus Arteriosus (PDA) device is a permanently implanted prosthesis indicated for percutaneous,...
St. Jude Medical Inc. launched the Amplatzer Vascular Plug 4 (AVP 4) in June 2012 for use in transcatheter embolization procedures (...
A device for excluding the left atrial appendage has received clearance from the FDA. AtriCure, Inc. has received clearance from the U.S....

Articles

Boston Scientific, Watchman LAA device, FDA approval
Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman...
ACC, iPad cardiology apps
DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.
Gore Helex, ASD occluder
The U.S. Food and Drug Administration (FDA) issued a warning this week about safety issues encountered with the St. Jude Amplatzer Atrial Septal Occluder (ASO...
PFM Medical
August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit-Occlud Patent Ductus Arteriosus (PDA)...

Video Center

The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
5 days 4 hours ago
It’s been no secret that the American healthcare system needed to change to survive economically...
6 weeks 5 days ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
8 weeks 5 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...